Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Adv Mater. 2020 Jun 15;32(30):e2001808. doi: 10.1002/adma.202001808

Figure 6.

Figure 6.

In vivo prophylactic and therapeutic efficacy. a) Experimental timeline for prophylactic efficacy study. b-d) Average tumor sizes (b), individual tumor growth kinetics (c), and survival (d) over time for the prophylactic efficacy study (n = 6; mean ± SEM). e) Experimental timeline for therapeutic efficacy study. f-h) Average tumor sizes (f), individual tumor growth kinetics (g), and survival (h) over time for the therapeutic efficacy study (n = 6; mean ± SEM). ** p < 0.01, *** p < 0.001 (compared to [CD80/OVA]NP in survival plot); log-rank test.